BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 20185762)

  • 41. Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.
    Brunmair B; Staniek K; Dörig J; Szöcs Z; Stadlbauer K; Marian V; Gras F; Anderwald C; Nohl H; Waldhäusl W; Fürnsinn C
    Diabetologia; 2006 Nov; 49(11):2713-22. PubMed ID: 16960684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
    Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
    Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor κB signalling in rat skeletal muscle cells by AMP-activated protein kinase.
    Green CJ; Macrae K; Fogarty S; Hardie DG; Sakamoto K; Hundal HS
    Biochem J; 2011 Apr; 435(2):463-74. PubMed ID: 21323644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amelioration of palmitate-induced insulin resistance in C₂C₁₂ muscle cells by rooibos (Aspalathus linearis).
    Mazibuko SE; Muller CJ; Joubert E; de Beer D; Johnson R; Opoku AR; Louw J
    Phytomedicine; 2013 Jul; 20(10):813-9. PubMed ID: 23639187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
    Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
    J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle.
    Ye JM; Tid-Ang J; Turner N; Zeng XY; Li HY; Cooney GJ; Wulff EM; Sauerberg P; Kraegen EW
    Br J Pharmacol; 2011 Jun; 163(3):556-66. PubMed ID: 21265823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
    Sebastián D; Herrero L; Serra D; Asins G; Hegardt FG
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E677-86. PubMed ID: 17062841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells.
    Cabrero A; Alegret M; Sanchez RM; Adzet T; Laguna JC; Carrera MV
    J Biol Chem; 2002 Mar; 277(12):10100-7. PubMed ID: 11792699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ligand-Activated Peroxisome Proliferator-Activated Receptor δ Attenuates Vascular Oxidative Stress by Inhibiting Thrombospondin-1 Expression.
    Ahn MY; Ham SA; Yoo T; Lee WJ; Hwang JS; Paek KS; Lim DS; Han SG; Lee CH; Seo HG
    J Vasc Res; 2018; 55(2):75-86. PubMed ID: 29408825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
    Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
    Salvadó L; Coll T; Gómez-Foix AM; Salmerón E; Barroso E; Palomer X; Vázquez-Carrera M
    Diabetologia; 2013 Jun; 56(6):1372-82. PubMed ID: 23460021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
    Djouadi F; Aubey F; Schlemmer D; Bastin J
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dimethyl itaconate attenuates palmitate-induced insulin resistance in skeletal muscle cells through the AMPK/FGF21/PPARδ-mediated suppression of inflammation.
    Park SY; Lee HJ; Song JH; Shin YK; Abd El-Aty AM; Ramadan A; Hacimuftuoglu A; Jeong JH; Jung TW
    Life Sci; 2021 Dec; 287():120129. PubMed ID: 34774619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages.
    Kemmerer M; Finkernagel F; Cavalcante MF; Abdalla DS; Müller R; Brüne B; Namgaladze D
    PLoS One; 2015; 10(6):e0130893. PubMed ID: 26098914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition.
    Kino T; Rice KC; Chrousos GP
    Eur J Clin Invest; 2007 May; 37(5):425-33. PubMed ID: 17461989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroxisome proliferator-activated receptor δ inhibits Porphyromonas gingivalis lipopolysaccharide-induced activation of matrix metalloproteinase-2 by downregulating NADPH oxidase 4 in human gingival fibroblasts.
    Yoo T; Ham SA; Hwang JS; Lee WJ; Paek KS; Oh JW; Kim JH; Do JT; Han CW; Kim JH; Seo HG
    Mol Oral Microbiol; 2016 Oct; 31(5):398-409. PubMed ID: 26403493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.